Intelgenx Technologies Corp (IGXT)
0.1619
-0.02
(-9.30%)
USD |
OTCM |
May 03, 16:00
Intelgenx Technologies 1 Year Total Returns (Daily): 16.56% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | 16.56% |
May 02, 2024 | 19.00% |
May 01, 2024 | 20.00% |
April 30, 2024 | 4.59% |
April 29, 2024 | 3.23% |
April 26, 2024 | -12.62% |
April 25, 2024 | -9.43% |
April 24, 2024 | -13.54% |
April 23, 2024 | -6.29% |
April 22, 2024 | -2.86% |
April 19, 2024 | -17.50% |
April 18, 2024 | -7.10% |
April 17, 2024 | -16.88% |
April 16, 2024 | -15.09% |
April 15, 2024 | -19.81% |
April 12, 2024 | 9.85% |
April 11, 2024 | 6.09% |
April 10, 2024 | 10.00% |
April 09, 2024 | 4.20% |
April 08, 2024 | 0.58% |
April 05, 2024 | -6.11% |
April 04, 2024 | 0.24% |
April 03, 2024 | -2.78% |
April 02, 2024 | -6.67% |
April 01, 2024 | -4.17% |
Date | Value |
---|---|
March 28, 2024 | -0.42% |
March 27, 2024 | 3.22% |
March 26, 2024 | -4.44% |
March 25, 2024 | -6.37% |
March 22, 2024 | -5.59% |
March 21, 2024 | -2.27% |
March 20, 2024 | -4.13% |
March 19, 2024 | -3.42% |
March 18, 2024 | 0.00% |
March 15, 2024 | 0.18% |
March 14, 2024 | -9.77% |
March 13, 2024 | 2.16% |
March 12, 2024 | -8.19% |
March 11, 2024 | -7.76% |
March 08, 2024 | 1.14% |
March 07, 2024 | -18.22% |
March 06, 2024 | -16.39% |
March 05, 2024 | -22.80% |
March 04, 2024 | -17.07% |
March 01, 2024 | -25.49% |
February 29, 2024 | -21.56% |
February 28, 2024 | -22.28% |
February 27, 2024 | -26.41% |
February 26, 2024 | -27.40% |
February 23, 2024 | -27.92% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-81.56%
Minimum
Mar 27 2020
313.9%
Maximum
Oct 18 2021
-5.19%
Average
-32.73%
Median
Mar 22 2022
1 Year Total Returns (Daily) Benchmarks
Acasti Pharma Inc | 10.17% |
Aurinia Pharmaceuticals Inc | -56.37% |
Edesa Biotech Inc | -40.91% |
Lexaria Bioscience Corp | 93.21% |
Xenon Pharmaceuticals Inc | 7.28% |